Overview
8 funds hold it, insiders have been net selling, and 1 straight earnings beat.
Key stats
Sep 5- Open
- $304.49
- 52-wk high
- $391.91
- High
- $307.55
- 52-wk low
- $280.25
- Low
- $302.51
- Prev close
- $307.99
- Mkt cap
- $118.14B
- P/E
- 32.4x
- Volume
- 2.40M
- Fwd P/E
- 19.0x
- Beta
- 0.77
- Div yield
- 1.11%
- P/S
- 4.6x
- P/B
- 5.1x
- Profit margin
- +14.4%
- Op margin
- +27.0%
- ROE
- +16.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 6.6% above what analysts expected.
Earnings per share
$3.46 expected
Reports Oct 29, 2026, in 54 days
EPS expected
$3.44 to $3.80
Revenue expected
25 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.06B | $7.17B | $6.02B | $6.59B |
| Cost of what it sold | $2.21B | $2.49B | $2.21B | $2.09B |
| Gross profit | $3.85B | $4.68B | $3.81B | $4.50B |
| What it spent | ||||
| Research and development | $410.0M | $401.0M | $413.0M | $434.0M |
| Sales and admin | $2.04B | $2.13B | $2.28B | $2.23B |
| Other operating costs | $262.0M | $180.0M | $180.0M | $176.0M |
| Total operating expenses | $2.72B | $2.72B | $2.87B | $2.84B |
| What was left | ||||
| Operating profit | $1.14B | $1.96B | $936.0M | $1.66B |
| Interest on debt | $157.0M | $381.0M | $148.0M | $141.0M |
| Profit before tax | $1.03B | $1.71B | $850.0M | $1.56B |
| Tax | $170.0M | $856.0M | $105.0M | $288.0M |
| Net profit | $859.0M | $849.0M | $745.0M | $1.28B |
| EBITDA | $1.36B | $2.03B | $1.30B | $1.56B |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Sapient Capital LLC Acquires 3,794 Shares of Stryker Corporation $SYK
Leans bullishSep 5NEOS Investment Management LLC Increases Stock Position in Stryker Corporation $SYK
BullishSep 5Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
NeutralSep 5Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
NeutralSep 4Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
NeutralSep 4Nykredit A S Makes New $88.91 Million Investment in Stryker Corporation $SYK
Leans bullishSep 3SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026
NeutralSep 3Continuum Advisory LLC Raises Stock Position in Stryker Corporation $SYK
Leans bullishSep 3
Macro
20 macro signals shaping SYK right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results